The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Diagnostics Service Market Research Report 2025

Global Cancer Diagnostics Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1730371

No of Pages : 89

Ask Your Query

Synopsis
Highlights
The global Cancer Diagnostics Service market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Cancer Diagnostics Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Cancer Diagnostics Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Cancer Diagnostics Service in Hospitals is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Cancer Diagnostics Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc., etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Breast Cancer, which accounted for % of the global market of Cancer Diagnostics Service in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics Service.
The Cancer Diagnostics Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cancer Diagnostics Service market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Diagnostics Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • Abbott
  • QIAGEN
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Applied DNA Sciences

Product Type Insights
Global markets are presented by Cancer Diagnostics Service type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Cancer Diagnostics Service are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Cancer Diagnostics Service segment by Type

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Others

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Cancer Diagnostics Service market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cancer Diagnostics Service market.
Cancer Diagnostics Service Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cancer Diagnostics Service market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Diagnostics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Cancer Diagnostics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cancer Diagnostics Service industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Diagnostics Service.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Diagnostics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Breast Cancer
1.2.3 Blood Cancer
1.2.4 Lung Cancer
1.2.5 Colorectal Cancer
1.2.6 Ovarian Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Diagnostics Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Diagnostics Service Market Perspective (2017-2028)
2.2 Cancer Diagnostics Service Growth Trends by Region
2.2.1 Cancer Diagnostics Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Diagnostics Service Historic Market Size by Region (2017-2022)
2.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2023-2028)
2.3 Cancer Diagnostics Service Market Dynamics
2.3.1 Cancer Diagnostics Service Industry Trends
2.3.2 Cancer Diagnostics Service Market Drivers
2.3.3 Cancer Diagnostics Service Market Challenges
2.3.4 Cancer Diagnostics Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Diagnostics Service Players by Revenue
3.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2017-2022)
3.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Diagnostics Service Revenue
3.4 Global Cancer Diagnostics Service Market Concentration Ratio
3.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2021
3.5 Cancer Diagnostics Service Key Players Head office and Area Served
3.6 Key Players Cancer Diagnostics Service Product Solution and Service
3.7 Date of Enter into Cancer Diagnostics Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Diagnostics Service Breakdown Data by Type
4.1 Global Cancer Diagnostics Service Historic Market Size by Type (2017-2022)
4.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2023-2028)
5 Cancer Diagnostics Service Breakdown Data by Application
5.1 Global Cancer Diagnostics Service Historic Market Size by Application (2017-2022)
5.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Diagnostics Service Market Size (2017-2028)
6.2 North America Cancer Diagnostics Service Market Size by Country (2017-2022)
6.3 North America Cancer Diagnostics Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Diagnostics Service Market Size (2017-2028)
7.2 Europe Cancer Diagnostics Service Market Size by Country (2017-2022)
7.3 Europe Cancer Diagnostics Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Service Market Size (2017-2028)
8.2 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Diagnostics Service Market Size (2017-2028)
9.2 Latin America Cancer Diagnostics Service Market Size by Country (2017-2022)
9.3 Latin America Cancer Diagnostics Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Service Market Size (2017-2028)
10.2 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Cancer Diagnostics Service Introduction
11.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2017-2022)
11.1.5 Illumina Recent Development
11.2 BGI Genomics Co.,Ltd.
11.2.1 BGI Genomics Co.,Ltd. Company Detail
11.2.2 BGI Genomics Co.,Ltd. Business Overview
11.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction
11.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2017-2022)
11.2.5 BGI Genomics Co.,Ltd. Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Cancer Diagnostics Service Introduction
11.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2017-2022)
11.3.5 Agilent Technologies Recent Development
11.4 Macrogen
11.4.1 Macrogen Company Detail
11.4.2 Macrogen Business Overview
11.4.3 Macrogen Cancer Diagnostics Service Introduction
11.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2017-2022)
11.4.5 Macrogen Recent Development
11.5 Pacific Biosciences
11.5.1 Pacific Biosciences Company Detail
11.5.2 Pacific Biosciences Business Overview
11.5.3 Pacific Biosciences Cancer Diagnostics Service Introduction
11.5.4 Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2017-2022)
11.5.5 Pacific Biosciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Cancer Diagnostics Service Introduction
11.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2017-2022)
11.6.5 Abbott Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Cancer Diagnostics Service Introduction
11.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2017-2022)
11.7.5 QIAGEN Recent Development
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Detail
11.8.2 Siemens Healthcare GmbH Business Overview
11.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction
11.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2017-2022)
11.8.5 Siemens Healthcare GmbH Recent Development
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Detail
11.9.2 Thermo Fisher Scientific, Inc. Business Overview
11.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction
11.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2017-2022)
11.9.5 Thermo Fisher Scientific, Inc. Recent Development
11.10 Applied DNA Sciences
11.10.1 Applied DNA Sciences Company Detail
11.10.2 Applied DNA Sciences Business Overview
11.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction
11.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2017-2022)
11.10.5 Applied DNA Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Breast Cancer
Table 3. Key Players of Blood Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Colorectal Cancer
Table 6. Key Players of Ovarian Cancer
Table 7. Key Players of Others
Table 8. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Cancer Diagnostics Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Cancer Diagnostics Service Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Cancer Diagnostics Service Market Share by Region (2017-2022)
Table 12. Global Cancer Diagnostics Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Cancer Diagnostics Service Market Share by Region (2023-2028)
Table 14. Cancer Diagnostics Service Market Trends
Table 15. Cancer Diagnostics Service Market Drivers
Table 16. Cancer Diagnostics Service Market Challenges
Table 17. Cancer Diagnostics Service Market Restraints
Table 18. Global Cancer Diagnostics Service Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Cancer Diagnostics Service Market Share by Players (2017-2022)
Table 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2021)
Table 21. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Diagnostics Service Product Solution and Service
Table 25. Date of Enter into Cancer Diagnostics Service Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Diagnostics Service Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Cancer Diagnostics Service Revenue Market Share by Type (2017-2022)
Table 29. Global Cancer Diagnostics Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Cancer Diagnostics Service Revenue Market Share by Type (2023-2028)
Table 31. Global Cancer Diagnostics Service Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Cancer Diagnostics Service Revenue Market Share by Application (2017-2022)
Table 33. Global Cancer Diagnostics Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Cancer Diagnostics Service Revenue Market Share by Application (2023-2028)
Table 35. North America Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
Table 45. Illumina Company Detail
Table 46. Illumina Business Overview
Table 47. Illumina Cancer Diagnostics Service Product
Table 48. Illumina Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 49. Illumina Recent Development
Table 50. BGI Genomics Co.,Ltd. Company Detail
Table 51. BGI Genomics Co.,Ltd. Business Overview
Table 52. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product
Table 53. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 54. BGI Genomics Co.,Ltd. Recent Development
Table 55. Agilent Technologies Company Detail
Table 56. Agilent Technologies Business Overview
Table 57. Agilent Technologies Cancer Diagnostics Service Product
Table 58. Agilent Technologies Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 59. Agilent Technologies Recent Development
Table 60. Macrogen Company Detail
Table 61. Macrogen Business Overview
Table 62. Macrogen Cancer Diagnostics Service Product
Table 63. Macrogen Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 64. Macrogen Recent Development
Table 65. Pacific Biosciences Company Detail
Table 66. Pacific Biosciences Business Overview
Table 67. Pacific Biosciences Cancer Diagnostics Service Product
Table 68. Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 69. Pacific Biosciences Recent Development
Table 70. Abbott Company Detail
Table 71. Abbott Business Overview
Table 72. Abbott Cancer Diagnostics Service Product
Table 73. Abbott Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 74. Abbott Recent Development
Table 75. QIAGEN Company Detail
Table 76. QIAGEN Business Overview
Table 77. QIAGEN Cancer Diagnostics Service Product
Table 78. QIAGEN Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 79. QIAGEN Recent Development
Table 80. Siemens Healthcare GmbH Company Detail
Table 81. Siemens Healthcare GmbH Business Overview
Table 82. Siemens Healthcare GmbH Cancer Diagnostics Service Product
Table 83. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 84. Siemens Healthcare GmbH Recent Development
Table 85. Thermo Fisher Scientific, Inc. Company Detail
Table 86. Thermo Fisher Scientific, Inc. Business Overview
Table 87. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product
Table 88. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 89. Thermo Fisher Scientific, Inc. Recent Development
Table 90. Applied DNA Sciences Company Detail
Table 91. Applied DNA Sciences Business Overview
Table 92. Applied DNA Sciences Cancer Diagnostics Service Product
Table 93. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
Table 94. Applied DNA Sciences Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Diagnostics Service Market Share by Type: 2021 VS 2028
Figure 2. Breast Cancer Features
Figure 3. Blood Cancer Features
Figure 4. Lung Cancer Features
Figure 5. Colorectal Cancer Features
Figure 6. Ovarian Cancer Features
Figure 7. Others Features
Figure 8. Global Cancer Diagnostics Service Market Share by Application in 2021 & 2028
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Cancer Diagnostics Service Report Years Considered
Figure 14. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Cancer Diagnostics Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Cancer Diagnostics Service Market Share by Region: 2021 VS 2028
Figure 17. Global Cancer Diagnostics Service Market Share by Players in 2021
Figure 18. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2021
Figure 20. North America Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Cancer Diagnostics Service Market Share by Country (2017-2028)
Figure 22. United States Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Cancer Diagnostics Service Market Share by Country (2017-2028)
Figure 26. Germany Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Cancer Diagnostics Service Market Share by Region (2017-2028)
Figure 34. China Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Cancer Diagnostics Service Market Share by Country (2017-2028)
Figure 42. Mexico Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2017-2028)
Figure 46. Turkey Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 49. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 50. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 51. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 52. Pacific Biosciences Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 53. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 54. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 55. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 56. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 57. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock